Jonathan Schapiro
MD
National Hemophilia Center, Sheba Medical Center, Israel
Related Materials
This program was specially tailored towards the management of complex HIV patients in Europe. The program focusing on the management of these patients in the United States took place on 15 September 2020. For information, click here.
Despite improved antiretroviral regimens, virological failure and the emergence of drug resistance remains an ongoing challenge throughout Europe. This includes both patients recently infected as well as veterans of older regimens. Although the resources, diagnostics, and soon drugs, required for the improved care of complex patients are now available in many parts of Europe, there remains a knowledge gap in how to best use them. Acquiring and interpreting resistance data correctly, incorporating co-morbidities and co-medications data, and then deciding on the optimal next regimen for patients with limited treatment options requires a high level of expertise. Managing these complex HIV patients require a greater knowledge and understanding in terms of adherence, resistance, aging, comorbidities, and polypharmacy.
This webinar was designed for European HIV physicians who would like to improve their knowledge of identifying and managing patients with limited treatment options, as well as new antiretroviral drugs for optimizing the treatment of these patients.
This interactive 3-hour webinar took place on 24 November 2020 at 15:00 CET and provided the most up-to-date information from international experts.
MD
National Hemophilia Center, Sheba Medical Center, Israel